Triluma
is a skin cream used to treat melasma, a common skin condition that causes brown patches or discoloration on the face. The cream contains three active ingredients, fluocinolone acetonide, hydroquinone, and tretinoin, which work together to reduce the production of melanin in the skin and promote the turnover of skin cells.
Fluocinolone acetonide is a corticosteroid that helps to reduce inflammation and itching in the skin, while hydroquinone is a depigmenting agent that helps to lighten the skin by reducing the amount of melanin produced. Tretinoin is a retinoid that helps to promote the turnover of skin cells, revealing new, healthy skin.
Triluma is applied topically to the affected areas of skin once daily, preferably in the evening, after washing and drying the skin. The cream should be used for a limited duration as directed by a Dermatologist and should not be used for cosmetic purposes.
While Triluma is generally safe and effective for treating melasma, it may cause mild side effects such as dryness, redness, and peeling of the skin. In rare cases, more serious side effects such as severe allergic reactions or skin thinning may occur. Patients should discuss any concerns or adverse reactions with their Dermatologist immediately.
Overall, Triluma is a safe and effective treatment for melasma when used as directed under the supervision of a Dermatologist. It can improve the appearance of the skin and boost self-confidence, but patients should be aware of the potential side effects and discuss any concerns with their Dermatologist.